The IVD testing market is one of the fastest-growing segments within the MedTech industry. As the demand for IVD testing grows, manufacturers are frantically trying to innovate to carve out market share for themselves. There will be more innovative solutions required to meet the growing need for more accurate and faster results. Patients and physicians alike are demanding effective and streamlined tests to determine disease and illness better to increase the quality of health received and provided. The quality of the information delivered by an IVD is assessed by measuring the test’s analytical precision or assay and by the clinical evidence of the information provided. We all understand how important it is to be very precise, specifically when testing or blood-typing (identifying blood type) or blood screening for HIV, and Hepatitis C, among others. We all understand the clinical relevance of these assays. This is why those IVDs which have the highest potential risk on the population do have exact performance criteria officially listed in the Common Technical Specifications, which are standards that control IVDs.
We at MedTech Outlook firmly believe that IVDs represent an inexpensive route towards more accurate and rapid patient care, translating into potential reductions in procedural and therapeutic costs. To help CIOs find the best solutions, a distinguished panel comprising CEOs, CIOs, analysts, and the Medtech Outlook’s editorial board has selected the leading IVDs Technology Solution Providers from the Middle East. In our selection, we looked at the vendor’s capability to fulfill the burning need for cost-effective and flexible solutions that add value to the IVDs landscape. We present to you Medtech Outlook’s “Top 10 In Vitro Diagnostics Solution Providers - 2020.”